Asia-Pacific Benign Prostatic Hyperplasia (BPH) Drugs Market Analysis 2012-2017 and Forecast 2018-2023

April 2018 | 115 pages | ID: A2098AEF526EN
99Strategy

Abstracts

SNAPSHOT

The Asia-Pacific Benign Prostatic Hyperplasia (BPH) Drugs market will reach xxx Million USD in 2018 and CAGR xx% 2018-2023. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Benign Prostatic Hyperplasia (BPH) Drugs by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):

• Alpha-blocker
• Phosphodiesterase Type-5 Inhibitors
• 5-alpha-Reductase Inhibitors

Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):

• Astellas Pharma
• Eli Lilly
• GlaxoSmithKline
• Sanofi
• ADC Therapeutics
• Bayer HealthCare
• Bristol-Myers Squibb
• Valeant Pharmaceuticals
• Endo Pharmaceuticals
• Foresee Pharmaceuticals
• Madrigal Pharmaceuticals
• Merck
• Novartis
• Spectrum Pharmaceuticals
• Takeda Pharmaceuticals
• Teva
• Advaxis
• ANI Pharmaceuticals
• BHR Pharma

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):

• Hospitals
• Clinics
• Others

Region Coverage (Regional Production, Demand & Forecast by Regions etc.):

• China
• Japan & Korea
• India
• Southeast Asia
• Oceania

Contents

1 INDUSTRY OVERVIEW

1.1 Benign Prostatic Hyperplasia (BPH) Drugs Industry
  1.1.1 Overview
  1.1.2 Development of Benign Prostatic Hyperplasia (BPH) Drugs
1.2 Market Segment
  1.2.1 By Product Type
  1.2.2 By Application
1.3 Asia-Pacific Overview

2 MAJOR COMPANIES LIST

2.1 Astellas Pharma (Company Profile, Products & Services, Sales Data etc.)
2.2 Eli Lilly (Company Profile, Products & Services, Sales Data etc.)
2.3 GlaxoSmithKline (Company Profile, Products & Services, Sales Data etc.)
2.4 Sanofi (Company Profile, Products & Services, Sales Data etc.)
2.5 ADC Therapeutics (Company Profile, Products & Services, Sales Data etc.)
2.6 Bayer HealthCare (Company Profile, Products & Services, Sales Data etc.)
2.7 Bristol-Myers Squibb (Company Profile, Products & Services, Sales Data etc.)
2.8 Valeant Pharmaceuticals (Company Profile, Products & Services, Sales Data etc.)
2.9 Endo Pharmaceuticals (Company Profile, Products & Services, Sales Data etc.)
2.10 Foresee Pharmaceuticals (Company Profile, Products & Services, Sales Data etc.)
2.11 Madrigal Pharmaceuticals (Company Profile, Products & Services, Sales Data etc.)
2.12 Merck (Company Profile, Products & Services, Sales Data etc.)
2.13 Novartis (Company Profile, Products & Services, Sales Data etc.)
2.14 Spectrum Pharmaceuticals (Company Profile, Products & Services, Sales Data etc.)
2.15 Takeda Pharmaceuticals (Company Profile, Products & Services, Sales Data etc.)
2.16 Teva (Company Profile, Products & Services, Sales Data etc.)
2.17 Advaxis (Company Profile, Products & Services, Sales Data etc.)
2.18 ANI Pharmaceuticals (Company Profile, Products & Services, Sales Data etc.)
2.19 BHR Pharma (Company Profile, Products & Services, Sales Data etc.)

3 MARKET COMPETITION

3.1 Company Competition
3.2 Regional Market by Company

4 BENIGN PROSTATIC HYPERPLASIA (BPH) DRUGS MARKET BY TYPE

4.1 By Type
  4.1.1 Alpha-blocker
  4.1.2 Phosphodiesterase Type-5 Inhibitors
  4.1.3 5-alpha-Reductase Inhibitors
4.2 Market Size
4.3 Market Forecast

5 MARKET DEMAND

5.1 Demand Situation
  5.1.1 Demand in Hospitals
  5.1.2 Demand in Clinics
  5.1.3 Demand in Others
5.2 Regional Demand Comparison
5.3 Demand Forecast

6 REGION OPERATION

6.1 Regional Production
6.2 Regional Market
6.3 by Region
  6.3.1 China
    6.3.1.1 By Type
    6.3.1.2 By Application
  6.3.2 Japan & Korea
    6.3.2.1 By Type
    6.3.2.2 By Application
  6.3.3 India
    6.3.3.1 By Type
    6.3.3.2 By Application
  6.3.4 Southeast Asia
    6.3.4.1 By Type
    6.3.4.2 By Application
  6.3.5 Oceania
    6.3.5.1 By Type
    6.3.5.2 By Application
6.4 Regional Forecast

7 MARKETING & PRICE

7.1 Price and Margin
  7.1.1 Price Trends
  7.1.2 Factors of Price Change
  7.1.3 Manufacturers Gross Margin Analysis
7.2 Marketing Channel

8 UPSTREAM & COST

8.1 Upstream
8.2 Cost

9 INDUSTRY ENVIRONMENT

9.1 Policy
9.2 Economics
9.3 Sociology
9.4 Technology

10 RESEARCH CONCLUSION

List Of Tables

LIST OF TABLES

Table Product Segment of Benign Prostatic Hyperplasia (BPH) Drugs
Table Asia-Pacific Benign Prostatic Hyperplasia (BPH) Drugs Market 2012-2023, by Product Type, in USD Million
Table Application Segment of Benign Prostatic Hyperplasia (BPH) Drugs
Table Asia-Pacific Benign Prostatic Hyperplasia (BPH) Drugs Market 2012-2023, by Application, in USD Million
Table Astellas Pharma Overview List
Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Astellas Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Eli Lilly Overview List
Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Eli Lilly (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GlaxoSmithKline Overview List
Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of GlaxoSmithKline (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sanofi Overview List
Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table ADC Therapeutics Overview List
Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of ADC Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bayer HealthCare Overview List
Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Bayer HealthCare (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bristol-Myers Squibb Overview List
Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Valeant Pharmaceuticals Overview List
Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Valeant Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Endo Pharmaceuticals Overview List
Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Endo Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Foresee Pharmaceuticals Overview List
Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Foresee Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Madrigal Pharmaceuticals Overview List
Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Madrigal Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck Overview List
Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novartis Overview List
Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Spectrum Pharmaceuticals Overview List
Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Spectrum Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Takeda Pharmaceuticals Overview List
Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Takeda Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Teva Overview List
Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Teva (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Advaxis Overview List
Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Advaxis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table ANI Pharmaceuticals Overview List
Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of ANI Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table BHR Pharma Overview List
Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of BHR Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Asia-Pacific Benign Prostatic Hyperplasia (BPH) Drugs Sales Revenue 2012-2017, by Company, in USD Million
Table Asia-Pacific Benign Prostatic Hyperplasia (BPH) Drugs Sales Revenue Share, by Company, in USD Million
Table Asia-Pacific Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume 2012-2017, by Company, in Volume
Table Asia-Pacific Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Share 2012-2017, by Company, in Volume
Table Major Company List of Alpha-blocker
Table Major Company List of Phosphodiesterase Type-5 Inhibitors
Table Major Company List of 5-alpha-Reductase Inhibitors
Table Asia-Pacific Benign Prostatic Hyperplasia (BPH) Drugs Market 2012-2017, by Type, in USD Million
Table Asia-Pacific Benign Prostatic Hyperplasia (BPH) Drugs Market 2012-2017, by Type, in Volume
Table Asia-Pacific Benign Prostatic Hyperplasia (BPH) Drugs Market Forecast 2018-2023, by Type, in USD Million
Table Asia-Pacific Benign Prostatic Hyperplasia (BPH) Drugs Market Forecast 2018-2023, by Type, in Volume
Table Benign Prostatic Hyperplasia (BPH) Drugs Demand in Hospitals, 2012-2017, in USD Million
Table Benign Prostatic Hyperplasia (BPH) Drugs Demand in Hospitals, 2012-2017, in Volume
Table Major Consumers in Hospitals
Table Benign Prostatic Hyperplasia (BPH) Drugs Demand in Clinics, 2012-2017, in USD Million
Table Benign Prostatic Hyperplasia (BPH) Drugs Demand in Clinics, 2012-2017, in Volume
Table Major Consumers in Clinics
Table Benign Prostatic Hyperplasia (BPH) Drugs Demand in Others, 2012-2017, in USD Million
Table Benign Prostatic Hyperplasia (BPH) Drugs Demand in Others, 2012-2017, in Volume
Table Major Consumers in Others
Table Regional Demand Comparison List
Table Major Application in Different Regions
Table Benign Prostatic Hyperplasia (BPH) Drugs Demand Forecast 2018-2023, by Application, in USD Million
Table Benign Prostatic Hyperplasia (BPH) Drugs Demand Forecast 2018-2023, by Application, in Volume
Table Benign Prostatic Hyperplasia (BPH) Drugs Production 2012-2017, by Region, in USD Million
Table Benign Prostatic Hyperplasia (BPH) Drugs Production 2012-2017, by Region, in Volume
Table Asia-Pacific Benign Prostatic Hyperplasia (BPH) Drugs Market Size 2012-2017, by Region, in USD Million
Table Asia-Pacific Benign Prostatic Hyperplasia (BPH) Drugs Market Size 2012-2017, by Region, in Volume
Table China Benign Prostatic Hyperplasia (BPH) Drugs Market Size 2012-2017, by Type, in USD Million
Table China Benign Prostatic Hyperplasia (BPH) Drugs Market Size 2012-2017, by Type, in Volume
Table China Benign Prostatic Hyperplasia (BPH) Drugs Market Size 2012-2017, by Application, in USD Million
Table China Benign Prostatic Hyperplasia (BPH) Drugs Market Size 2012-2017, by Application, in Volume
Table Japan & Korea Benign Prostatic Hyperplasia (BPH) Drugs Market Size 2012-2017, by Country, in USD Million
Table Japan & Korea Benign Prostatic Hyperplasia (BPH) Drugs Market Size 2012-2017, by Country, in Volume
Table Japan Benign Prostatic Hyperplasia (BPH) Drugs Market Size 2012-2017, by Type, in USD Million
Table Japan Benign Prostatic Hyperplasia (BPH) Drugs Market Size 2012-2017, by Type, in Volume
Table Japan Benign Prostatic Hyperplasia (BPH) Drugs Market Size 2012-2017, by Application, in USD Million
Table Japan Benign Prostatic Hyperplasia (BPH) Drugs Market Size 2012-2017, by Application, in Volume
Table India Benign Prostatic Hyperplasia (BPH) Drugs Market Size 2012-2017, by Country, in USD Million
Table India Benign Prostatic Hyperplasia (BPH) Drugs Market Size 2012-2017, by Country, in Volume
Table India Benign Prostatic Hyperplasia (BPH) Drugs Market Size 2012-2017, by Type, in USD Million
Table India Benign Prostatic Hyperplasia (BPH) Drugs Market Size 2012-2017, by Type, in Volume
Table India Benign Prostatic Hyperplasia (BPH) Drugs Market Size 2012-2017, by Application, in USD Million
Table India Benign Prostatic Hyperplasia (BPH) Drugs Market Size 2012-2017, by Application, in Volume
Table Southeast Asia Benign Prostatic Hyperplasia (BPH) Drugs Market Size 2012-2017, by Country, in USD Million
Table Southeast Asia Benign Prostatic Hyperplasia (BPH) Drugs Market Size 2012-2017, by Country, in Volume
Table Southeast Asia Benign Prostatic Hyperplasia (BPH) Drugs Market Size 2012-2017, by Type, in USD Million
Table Southeast Asia Benign Prostatic Hyperplasia (BPH) Drugs Market Size 2012-2017, by Type, in Volume
Table Southeast Asia Benign Prostatic Hyperplasia (BPH) Drugs Market Size 2012-2017, by Application, in USD Million
Table Southeast Asia Benign Prostatic Hyperplasia (BPH) Drugs Market Size 2012-2017, by Application, in Volume
Table Oceania Benign Prostatic Hyperplasia (BPH) Drugs Market Size 2012-2017, by Country, in USD Million
Table Oceania Benign Prostatic Hyperplasia (BPH) Drugs Market Size 2012-2017, by Country, in Volume
Table Oceania Benign Prostatic Hyperplasia (BPH) Drugs Market Size 2012-2017, by Type, in USD Million
Table Oceania Benign Prostatic Hyperplasia (BPH) Drugs Market Size 2012-2017, by Type, in Volume
Table Oceania Benign Prostatic Hyperplasia (BPH) Drugs Market Size 2012-2017, by Application, in USD Million
Table Oceania Benign Prostatic Hyperplasia (BPH) Drugs Market Size 2012-2017, by Application, in Volume
Table Benign Prostatic Hyperplasia (BPH) Drugs Market Forecast 2018-2023, by Region, in USD Million
Table Benign Prostatic Hyperplasia (BPH) Drugs Market Forecast 2018-2023, by Region, in Volume
Table Price Factors List
Table Upstream Segment of Benign Prostatic Hyperplasia (BPH) Drugs

List Of Figures

LIST OF FIGURES

Figure Benign Prostatic Hyperplasia (BPH) Drugs Industry Chain Structure
Figure Asia-Pacific Benign Prostatic Hyperplasia (BPH) Drugs Market Size and Growth Rate 2012-2023
Figure China Benign Prostatic Hyperplasia (BPH) Drugs Market, by Company, in 2018
Figure Japan & Korea Benign Prostatic Hyperplasia (BPH) Drugs Market, by Company, in 2018
Figure India Benign Prostatic Hyperplasia (BPH) Drugs Market, by Company, in 2018
Figure Southeast Asia Benign Prostatic Hyperplasia (BPH) Drugs Market, by Company, in 2018
Figure Oceania Benign Prostatic Hyperplasia (BPH) Drugs Market, by Company, in 2018
Figure Asia-Pacific Benign Prostatic Hyperplasia (BPH) Drugs Market Growth 2012-2017, by Type, in USD Million
Figure Asia-Pacific Benign Prostatic Hyperplasia (BPH) Drugs Market Growth 2012-2017, by Type, in Volume
Figure China Benign Prostatic Hyperplasia (BPH) Drugs Market Size and Growth 2012-2017, in USD Million
Figure China Benign Prostatic Hyperplasia (BPH) Drugs Market Size and Growth 2012-2017, in Volume
Figure Japan & Korea Benign Prostatic Hyperplasia (BPH) Drugs Market Size and Growth 2012-2017, in USD Million
Figure Japan & Korea Benign Prostatic Hyperplasia (BPH) Drugs Market Size and Growth 2012-2017, in Volume
Figure India Benign Prostatic Hyperplasia (BPH) Drugs Market Size and Growth 2012-2017, in USD Million
Figure India Benign Prostatic Hyperplasia (BPH) Drugs Market Size and Growth 2012-2017, in Volume
Figure Southeast Asia Benign Prostatic Hyperplasia (BPH) Drugs Market Size and Growth 2012-2017, in USD Million
Figure Southeast Asia Benign Prostatic Hyperplasia (BPH) Drugs Market Size and Growth 2012-2017, in Volume
Figure Oceania Benign Prostatic Hyperplasia (BPH) Drugs Market Size and Growth 2012-2017, in USD Million
Figure Oceania Benign Prostatic Hyperplasia (BPH) Drugs Market Size and Growth 2012-2017, in Volume
Figure Marketing Channels Overview